pDONR223 SARS-CoV-2 NSP5 Citations (2)
Originally described in: A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.Kim DK, Knapp JJ, Kuang D, Chawla A, Cassonnet P, Lee H, Sheykhkarimli D, Samavarchi-Tehrani P, Abdouni H, Rayhan A, Li R, Pogoutse O, Coyaud E, van der Werf S, Demeret C, Gingras AC, Taipale M, Raught B, Jacob Y, Roth FP G3 (Bethesda). 2020 Aug 6. pii: g3.120.401554. doi: 10.1534/g3.120.401554. PubMed Journal
Articles Citing pDONR223 SARS-CoV-2 NSP5
Articles |
---|
A Bioluminescent 3CL(Pro) Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors. Mathieu C, Touret F, Jacquemin C, Janin YL, Nougairede A, Brailly M, Mazelier M, Decimo D, Vasseur V, Hans A, Valle-Casuso JC, de Lamballerie X, Horvat B, Andre P, Si-Tahar M, Lotteau V, Vidalain PO. Viruses. 2021 Sep 12;13(9). pii: v13091814. doi: 10.3390/v13091814. PubMed |
A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. Gerber PP, Duncan LM, Greenwood EJ, Marelli S, Naamati A, Teixeira-Silva A, Crozier TW, Gabaev I, Zhan JR, Mulroney TE, Horner EC, Doffinger R, Willis AE, Thaventhiran JE, Protasio AV, Matheson NJ. PLoS Pathog. 2022 Feb 10;18(2):e1010265. doi: 10.1371/journal.ppat.1010265. eCollection 2022 Feb. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.